Connect Biopharma Holdings Limited (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

2.140

-0.060 (-2.73%)

At close: Jul 24, 2026, 4:00 PM EDT

2.160

+0.020 (0.93%)

After-hours: Jul 24, 2026, 7:42 PM EDT

CNTB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Revenue	0.23	0.06	26.03	-	-	-
Revenue Growth (YoY)	-99.11%	-99.75%	-	-	-	-
Gross Profit	0.23	0.06	26.03	-	-	-
Selling, General & Admin	20.27	20.34	17.43	16.05	20.81	19.01
Research & Development	46.2	37.8	27.86	53	96.63	80.5
Other Operating Expenses	-	-	-	-	-1.08	-1.85
Operating Expenses	66.47	58.14	45.29	69.06	116.36	97.66
Operating Income	-66.23	-58.07	-19.25	-69.06	-116.36	-97.66
Interest Expense	-	-	-	-	-0.02	-0.01
Interest & Investment Income	1.81	2.27	4.45	5.22	1.81	0.17
Currency Exchange Gain (Loss)	-	-	-	-	1.47	-0.52
Other Non Operating Income (Expenses)	0.01	0.52	2.59	1.85	-	-103.98
EBT Excluding Unusual Items	-64.42	-55.28	-12.21	-61.99	-113.1	-202
Asset Writedown	-	-	-	-	-4.7	-
Other Unusual Items	-	-	-3.2	-	-	-
Pretax Income	-64.42	-55.28	-15.41	-61.99	-117.79	-202
Income Tax Expense	0.19	0.2	0.22	0.12	0.3	0.27
Earnings From Continuing Operations	-64.61	-55.48	-15.63	-62.11	-118.09	-202.27
Net Income	-64.61	-55.48	-15.63	-62.11	-118.09	-202.27
Net Income to Common	-64.61	-55.48	-15.63	-62.11	-118.09	-202.27
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	56	56	55	55	55	52
Shares Outstanding (Diluted)	56	56	55	55	55	52
Shares Change (YoY)	1.24%	0.81%	0.27%	0.04%	5.50%	205.31%
EPS (Basic)	-1.15	-1.00	-0.28	-1.13	-2.15	-3.88
EPS (Diluted)	-1.15	-1.00	-0.28	-1.13	-2.15	-3.88
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-57.61	-51.64	-24.36	-47.82	-105.93	-88.16
Free Cash Flow Per Share	-1.03	-0.93	-0.44	-0.87	-1.92	-1.69
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-28426.61%	-90740.63%	-73.95%	-	-	-
Profit Margin	-27727.90%	-86687.50%	-60.03%	-	-	-
Free Cash Flow Margin	-24723.18%	-80687.50%	-93.58%	-	-	-
EBITDA	-65.54	-57.37	-18.59	-68.34	-115.63	-97.17
EBITDA Margin	-	-	-71.42%	-	-	-
D&A For EBITDA	0.7	0.7	0.66	0.72	0.73	0.49
EBIT	-66.23	-58.07	-19.25	-69.06	-116.36	-97.66
EBIT Margin	-	-	-73.95%	-	-	-

SEC Filings: 10-K · 10-Q